- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Podcast
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Author(s):
In this episode, we dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource.
In this episode of The Cutaneous Connection, we cover the topics of how the idea for the The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas,” was developed, the work that went into getting the content for the book, and how will influence educational material for dermatology with co-editors Adam Friedman, MD, and Misty Eleryan, MD, MS.
Related Videos
Mechanism of Action Differences Among IL-17 Inhibitors
The Role of IL-17 in Psoriasis Pathogenesis
Future Directions for Pediatric Atopic Dermatitis Management and Research
New Systemic Therapies for Pediatric Atopic Dermatitis: Nemolizumab and Oral JAK Inhibitors
Pipeline Updates on the Horizon From Arcutis Biotherapeutics
LaShell Robinson on Takeda’s Initiative to Improve Research Diversity
New Systemic Therapies for Pediatric Atopic Dermatitis: Dupilumab and IL-13 Inhibitors
New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Tapinarof
Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PN
Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally
Related Content
